shutterstock_728418391_casimiro_pt
casimiropt / Shutterstock.com
7 May 2019Big Pharma

English High Court invalidates Allergan glaucoma patent

One of  Allergan’s patents has been invalidated after it was challenged by UK-based pharmaceutical companies  Accord Healthcare and  Aspire Pharma.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
20 March 2019   Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case.
Big Pharma
18 March 2019   A district court must revisit its decision that one of Allergan’s patents is valid and was not infringed by a competitor.

More on this story

Big Pharma
20 March 2019   Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case.
Big Pharma
18 March 2019   A district court must revisit its decision that one of Allergan’s patents is valid and was not infringed by a competitor.

More on this story

Big Pharma
20 March 2019   Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case.
Big Pharma
18 March 2019   A district court must revisit its decision that one of Allergan’s patents is valid and was not infringed by a competitor.